These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

660 related items for PubMed ID: 1541059

  • 1. Reduction of urinary oxalate by combined calcium and citrate administration without increase in urinary calcium oxalate stone formers.
    Ito H, Suzuki F, Yamaguchi K, Nishikawa Y, Kotake T.
    Clin Nephrol; 1992 Jan; 37(1):14-8. PubMed ID: 1541059
    [Abstract] [Full Text] [Related]

  • 2. [Combined administration of calcium and citrate reduces urinary oxalate excretion].
    Ito H.
    Hinyokika Kiyo; 1991 Oct; 37(10):1107-10. PubMed ID: 1755399
    [Abstract] [Full Text] [Related]

  • 3. [Effect of cocoa on excretion of oxalate, citrate, magnesium and calcium in the urine of children].
    Lagemann M, Anders D, Graef V, Bödeker RH.
    Monatsschr Kinderheilkd; 1985 Oct; 133(10):754-9. PubMed ID: 4069117
    [Abstract] [Full Text] [Related]

  • 4. [Effect of verapamil on urinary calcium and oxalate excretion in renal stone formers].
    Iguchi M, Ikegami M, Kiwamoto H, Umekawa T, Ishikawa Y, Kohri K, Kurita T.
    Hinyokika Kiyo; 1993 May; 39(5):425-31. PubMed ID: 8322624
    [Abstract] [Full Text] [Related]

  • 5. [Reduction of urinary oxalate excretion by administration of calcium and citrate].
    Ito H, Yamaguchi K, Nishikawa Y, Kotake T.
    Nihon Hinyokika Gakkai Zasshi; 1989 Oct; 80(10):1417-21. PubMed ID: 2601215
    [Abstract] [Full Text] [Related]

  • 6. Promoters and inhibitors of calcium urolithiasis in children.
    Lama G, Carbone MG, Marrone N, Russo P, Spagnuolo G.
    Child Nephrol Urol; 1990 Oct; 10(2):81-4. PubMed ID: 2253256
    [Abstract] [Full Text] [Related]

  • 7. Study of inhibitor and nucleator activities in calcium stone formers.
    Duranti E, Imperiali P, Badii M, Capiccioni S, Masi MG, Sasdelli M.
    Proc Eur Dial Transplant Assoc; 1983 Oct; 20():445-9. PubMed ID: 6657667
    [Abstract] [Full Text] [Related]

  • 8. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D, Strazzullo P, Lotti T, Bianchi G, Borghi L, Caione P, Carini M, Caudarella R, Ferraro M, Gambaro G, Gelosa M, Guttilla A, Illiano E, Martino M, Meschi T, Messa P, Miano R, Napodano G, Nouvenne A, Rendina D, Rocco F, Rosa M, Sanseverino R, Salerno A, Spatafora S, Tasca A, Ticinesi A, Travaglini F, Trinchieri A, Vespasiani G, Zattoni F, CLU Working Group.
    Arch Ital Urol Androl; 2015 Jul 07; 87(2):105-20. PubMed ID: 26150027
    [Abstract] [Full Text] [Related]

  • 9. [Oxalate stone prophylaxis by alkalinizing therapy (author's transl)].
    Butz M.
    Urologe A; 1982 May 07; 21(3):142-6. PubMed ID: 7048691
    [Abstract] [Full Text] [Related]

  • 10. Reduction of renal stone risk by potassium-magnesium citrate during 5 weeks of bed rest.
    Zerwekh JE, Odvina CV, Wuermser LA, Pak CY.
    J Urol; 2007 Jun 07; 177(6):2179-84. PubMed ID: 17509313
    [Abstract] [Full Text] [Related]

  • 11. Prevention of stone formation and bone loss in absorptive hypercalciuria by combined dietary and pharmacological interventions.
    Pak CY, Heller HJ, Pearle MS, Odvina CV, Poindexter JR, Peterson RD.
    J Urol; 2003 Feb 07; 169(2):465-9. PubMed ID: 12544288
    [Abstract] [Full Text] [Related]

  • 12. Body size and 24-hour urine composition.
    Taylor EN, Curhan GC.
    Am J Kidney Dis; 2006 Dec 07; 48(6):905-15. PubMed ID: 17162145
    [Abstract] [Full Text] [Related]

  • 13. [Risk indicators of urinary calculus formation: value of oxalate and citrate excretion in comparison with the oxalate tolerance value].
    Hannak D, Burczyk U, Bartelt U, Kattermann R.
    Urologe A; 1989 Jan 07; 28(1):20-4. PubMed ID: 2922896
    [Abstract] [Full Text] [Related]

  • 14. Effect of citrate on the urinary excretion of calcium and oxalate: relevance to calcium oxalate nephrolithiasis.
    Cowley DM, McWhinney BC, Brown JM, Chalmers AH.
    Clin Chem; 1989 Jan 07; 35(1):23-8. PubMed ID: 2910576
    [Abstract] [Full Text] [Related]

  • 15. Physiological and physiochemical correction and prevention of calcium stone formation by potassium citrate therapy.
    Pak CY, Sakhaee K, Fuller CJ.
    Trans Assoc Am Physicians; 1983 Jan 07; 96():294-305. PubMed ID: 6679957
    [Abstract] [Full Text] [Related]

  • 16. Stone forming risk of calcium citrate supplementation in healthy postmenopausal women.
    Sakhaee K, Poindexter JR, Griffith CS, Pak CY.
    J Urol; 2004 Sep 07; 172(3):958-61. PubMed ID: 15311008
    [Abstract] [Full Text] [Related]

  • 17. Analysis of calcium, oxalate, and citrate interaction in idiopathic calcium urolithiasis in children.
    Milosević D, Batinić D, Konjevoda P, Blau N, Stambuk N, Nizić L, Vrljicak K, Batinić D.
    J Chem Inf Comput Sci; 2003 Sep 07; 43(6):1844-7. PubMed ID: 14632431
    [Abstract] [Full Text] [Related]

  • 18. Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation.
    Stoller ML, Chi T, Eisner BH, Shami G, Gentle DL.
    J Urol; 2009 Mar 07; 181(3):1140-4. PubMed ID: 19152919
    [Abstract] [Full Text] [Related]

  • 19. Urinary magnesium and oxalic acid excretion in patients with recurrent oxalate urolithiasis.
    Takasaki E.
    Invest Urol; 1975 Jan 07; 12(4):251-4. PubMed ID: 1112654
    [Abstract] [Full Text] [Related]

  • 20. Changes in urinary composition of calcium oxalate stone formers.
    Rahman B, Rahman MA.
    Biomed Pharmacother; 1986 Jan 07; 40(3):108-10. PubMed ID: 3742009
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.